MML Investors Services
RGNX icon

MML Investors Services’s Regenxbio RGNX Stock Holding History

MML Investors Services’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-6,432
Closed -$213K – 2130
2022
Q1 		$213K Sell
6,432
-518
-7% -$14.4K ﹤0.01% 1927
2021
Q4 		$227K Sell
6,950
-800
-10% -$27.2K ﹤0.01% 1855
2021
Q3 		$325K Sell
7,750
-24,750
-76% -$891K ﹤0.01% 1599
2021
Q2 		$1.26M Sell
32,500
-2,333
-7% -$83.4K 0.01% 903
2021
Q1 		$1.19M Sell
34,833
-5,992
-15% -$256K 0.01% 849
2020
Q4 		$1.85M Sell
40,825
-2,416
-6% -$84.4K 0.02% 622
2020
Q3 		$1.19M Buy
43,241
+4,690
+12% +$153K 0.01% 706
2020
Q2 		$1.42M Buy
38,551
+1,471
+4% +$54.8K 0.02% 614
2020
Q1 		$1.2M Buy
37,080
+1,194
+3% +$49.7K 0.02% 572
2019
Q4 		$1.47M Buy
35,886
+4,244
+13% +$168K 0.02% 578
2019
Q3 		$1.13M Buy
31,642
+3,192
+11% +$129K 0.02% 630
2019
Q2 		$1.46M Buy
28,450
+16,075
+130% +$803K 0.02% 589
2019
Q1 		$709K Buy
+12,375
New +$613K 0.01% 849

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

MML Investors Services's RGNX Position: Q2 2022 in Review

MML Investors Services sold out of Regenxbio (RGNX) in Q2 2022, closing a stake of 6,432 shares — an estimated $213K sold.

MML Investors Services first reported a position in RGNX in Q1 2019 and held it in 13 quarters. The position peaked at $1.85M in Q4 2020. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2022.

  • MML Investors Services reported no remaining Regenxbio position as of Q2 2022 after selling out during the quarter.
  • MML Investors Services sold 6,432 Regenxbio shares in Q2 2022, an estimated $213K.
  • MML Investors Services first reported a position in Regenxbio in Q1 2019 and held it in 13 quarters.
  • MML Investors Services's Regenxbio position peaked at $1.85M in Q4 2020.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2022.

Based on MML Investors Services's 13F filing for Q2 2022, filed 12 Aug 2022.